• Seon Young Kim, Ja Yoon Gu, Hyun Ju Yoo, Ji Eun Kim, Seonpyo Jang, Sooyeon Choe, Youngil Koh, Inho Kim, and Hyun Kyung Kim.
• Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
• Ann Lab Med. 2017 Nov 1; 37 (6): 484-493.

BackgroundThromboelastography (TEG) provides comprehensive information on the whole blood clot formation phases, whereas thrombin generation assay (TGA) reveals the endogenous thrombin levels in plasma. We investigated the potential significance of TEG and TGA parameters for prediction of clinical bleeding in hematologic patients on the basis of the patient's platelet levels.MethodsTEG and TGA were performed in 126 patients with thrombocytopenia or hematologic malignancies. The bleeding tendencies were stratified on the basis of the World Health Organization bleeding grade.ResultsMaximum amplitude (MA) and clot formation in TEG and endogenous thrombin potential (ETP) in TGA showed significant associations with high bleeding grades (P=0.001 and P=0.011, respectively). In patients with platelet counts ≤10×10⁹/L, low MA values were strongly associated with a high bleeding risk. For bleeding prediction, the area under the curve (AUC) of MA (0.857) and ETP (0.809) in patients with severe thrombocytopenia tended to be higher than that of platelets (0.740) in all patients. Patients with platelet counts ≤10×10⁹/L displayed the highest AUC of the combined MA and ETP (0.929).ConclusionsBoth TEG and TGA were considered to be good predictors of clinical bleeding in patients with severe thrombocytopenia. Combination of the ETP and MA values resulted in a more sensitive bleeding risk prediction in those with severe thrombocytopenia.© The Korean Society for Laboratory Medicine

34 keywords...

hide…